Total Payments
$282,689
2024 Payments
$15,708
Companies
95
Transactions
2,136
Medicare Patients
3,587
Medicare Billing
$415,419
Payment Breakdown by Category
Other$200,179 (70.8%)
Food & Beverage$33,297 (11.8%)
Consulting$27,515 (9.7%)
Travel$20,823 (7.4%)
Education$844.63 (0.3%)
Gifts$29.45 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $170,366 | 122 | 60.3% |
| Food and Beverage | $33,297 | 1,845 | 11.8% |
| Honoraria | $29,813 | 19 | 10.5% |
| Consulting Fee | $27,515 | 9 | 9.7% |
| Travel and Lodging | $20,823 | 114 | 7.4% |
| Education | $844.63 | 25 | 0.3% |
| Gift | $29.45 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $56,729 | 108 | $0 (2023) |
| SK Life Science, Inc. | $54,271 | 106 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $29,968 | 108 | $0 (2022) |
| ABBVIE INC. | $20,611 | 121 | $0 (2024) |
| Allergan, Inc. | $19,212 | 113 | $0 (2022) |
| Eisai Inc. | $17,970 | 57 | $0 (2024) |
| Neurelis, Inc. | $13,165 | 55 | $0 (2024) |
| UCB, Inc. | $12,787 | 101 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $11,090 | 14 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $10,678 | 41 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,708 | 330 | Eisai Inc. ($8,271) |
| 2023 | $17,056 | 251 | IDORSIA PHARMACEUTICALS US INC ($11,057) |
| 2022 | $30,425 | 240 | SK Life Science, Inc. ($12,900) |
| 2021 | $30,637 | 215 | SK Life Science, Inc. ($16,346) |
| 2020 | $69,804 | 224 | SK Life Science, Inc. ($24,778) |
| 2019 | $50,929 | 299 | Amgen Inc. ($37,460) |
| 2018 | $27,038 | 266 | UCB, Inc. ($9,252) |
| 2017 | $41,091 | 311 | Avanir Pharmaceuticals, Inc. ($19,700) |
All Payment Transactions
2,136 individual payment records from CMS Open Payments — Page 1 of 86
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Immunology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: EPILEPSY | ||||||
| 12/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.09 | General |
| 12/17/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Neurology | ||||||
| 12/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Immunology and Neurology | ||||||
| 12/03/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $12.13 | General |
| Category: Narcoplepsy | ||||||
| 12/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Neurology | ||||||
| 12/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/21/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $39.84 | General |
| Category: Immunology | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 681 | 1,027 | $193,909 | $81,131 |
| 2022 | 22 | 846 | 1,462 | $256,361 | $102,576 |
| 2021 | 21 | 956 | 1,432 | $272,624 | $123,557 |
| 2020 | 23 | 1,104 | 1,502 | $275,570 | $108,155 |
Total Patients
3,587
Total Services
5,423
Medicare Billing
$415,419
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 390 | $66,054 | $32,638 | 49.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 119 | 175 | $41,084 | $21,153 | 51.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 60 | $18,120 | $7,904 | 43.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 17 | 18 | $12,420 | $4,894 | 39.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 17 | 32 | $10,208 | $2,676 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $6,125 | $2,547 | 41.6% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 11 | 11 | $8,250 | $2,316 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 42 | $4,774 | $2,018 | 42.3% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 17 | 17 | $14,781 | $1,616 | 10.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 14 | 16 | $2,800 | $1,021 | 36.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 16 | 51 | $3,672 | $986.43 | 26.9% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 18 | 79 | $1,383 | $306.24 | 22.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 11 | 13 | $936.00 | $290.10 | 31.0% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 11 | 11 | $935.00 | $254.00 | 27.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 27 | $270.00 | $218.40 | 80.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 16 | 20 | $1,080 | $175.95 | 16.3% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 11 | 11 | $495.00 | $97.70 | 19.7% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 16 | 29 | $522.00 | $20.62 | 4.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 293 | 487 | $77,433 | $39,626 | 51.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 108 | 170 | $36,380 | $20,765 | 57.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 34 | 35 | $24,150 | $9,753 | 40.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 42 | $12,684 | $6,141 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 92 | $9,844 | $5,427 | 55.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $8,330 | $3,474 | 41.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 13 | 32 | $10,208 | $2,522 | 24.7% |
About Dr. Andrew Braunstein, D.O
Dr. Andrew Braunstein, D.O is a Neurology healthcare provider based in Mooresville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457343337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Braunstein, D.O has received a total of $282,689 in payments from pharmaceutical and medical device companies, with $15,708 received in 2024. These payments were reported across 2,136 transactions from 95 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($170,366).
As a Medicare-enrolled provider, Braunstein has provided services to 3,587 Medicare beneficiaries, totaling 5,423 services with total Medicare billing of $415,419. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Mooresville, NC
- Active Since 08/17/2005
- Last Updated 07/30/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1457343337
Products in Payments
- Aimovig (Biological) $56,526
- UBRELVY (Drug) $36,318
- XCOPRI (Drug) $34,123
- NUEDEXTA (Drug) $29,822
- Cenobamate (Drug) $19,266
- VALTOCO (Drug) $13,165
- Briviact (Drug) $12,132
- QUVIVIQ (Drug) $11,090
- Fycompa (Drug) $9,591
- APTIOM (Drug) $9,483
- Leqembi (Drug) $8,329
- OXTELLAR XR (Drug) $4,913
- APOKYN (Drug) $4,029
- TROKENDI XR (Drug) $3,451
- QULIPTA (Drug) $2,424
- ACTHAR (Biological) $2,236
- KYNMOBI (Drug) $1,299
- Austedo XR (Drug) $836.12
- TYSABRI (Biological) $799.17
- KESIMPTA (Drug) $749.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.